Kestra Advisory Services, LLC Novartis Ag Transaction History

Kestra Advisory Services, LLC

$19.6 Billion
Q1 2025

A detailed history of Kestra Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 29,639 shares of NVS stock, worth $3.43 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,639

Previous 37,726 21.44%

Holding current value

$3.43 Million

Previous $3.67 Million 10.0%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$97.14 - $115.57 $785,571 - $934,614	-8,087 Reduced 21.44%	29,639 $3.3 Million
Q4 2024 Feb 10, 2025	SELL	$96.78 - $117.18 $14.6 Million - $17.7 Million	-151,021 Reduced 80.01%	37,726 $3.67 Million
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $6,261 - $7,132	-59 Reduced 0.03%	188,747 $21.7 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $14.2 Million - $16.4 Million	153,096 Added 428.72%	188,806 $20.1 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $456,343 - $519,571	4,790 Added 15.49%	35,710 $3.45 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $116,813 - $128,549	1,266 Added 4.27%	30,920 $3.12 Million
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $3.11 Million - $3.45 Million	-32,828 Reduced 52.54%	29,654 $3.02 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $2.79 Million - $3.16 Million	30,130 Added 93.13%	62,482 $6.31 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $1.25 Million - $1.45 Million	-15,609 Reduced 32.55%	32,352 $2.98 Million
Q4 2022 Jan 31, 2023	SELL	$75.55 - $92.52 $1.86 Million - $2.27 Million	-24,585 Reduced 33.89%	47,961 $4.35 Million
Q3 2022 Nov 01, 2022	BUY	$74.61 - $87.26 $2.57 Million - $3.01 Million	34,499 Added 90.67%	72,546 $5.51 Billion
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $341,968 - $398,156	4,247 Added 12.57%	38,047 $3.22 Million
Q1 2022 Apr 26, 2022	SELL	$80.11 - $90.62 $2.37 Million - $2.69 Million	-29,630 Reduced 46.71%	33,800 $2.97 Million
Q4 2021 Jan 20, 2022	SELL	$79.7 - $88.13 $3.96 Million - $4.38 Million	-49,738 Reduced 43.95%	63,430 $5.55 Million
Q3 2021 Oct 19, 2021	BUY	$81.78 - $95.14 $3.85 Million - $4.48 Million	47,127 Added 71.36%	113,168 $9.25 Million
Q2 2021 Jul 28, 2021	SELL	$85.24 - $94.15 $199,205 - $220,028	-2,337 Reduced 3.42%	66,041 $6.03 Million
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $4.23 Million - $4.99 Million	-50,665 Reduced 42.56%	68,378 $5.84 Million
Q4 2020 Jan 20, 2021	BUY	$78.07 - $94.43 $4.68 Million - $5.66 Million	59,965 Added 101.5%	119,043 $11.2 Billion
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $4.85 Million - $5.38 Million	59,078 New	59,078 $5.14 Billion

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Novartis Ag Transaction History